Show simple item record

Autoimmune progesterone dermatitis in a patient with endometriosis: case report and review of the literature

dc.contributor.authorBaptist, Alan P
dc.contributor.authorBaldwin, James L
dc.date.accessioned2015-08-07T17:30:40Z
dc.date.available2015-08-07T17:30:40Z
dc.date.issued2004-08-02
dc.identifier.citationClinical and Molecular Allergy. 2004 Aug 02;2(1):10
dc.identifier.urihttps://hdl.handle.net/2027.42/112472en_US
dc.description.abstractAbstract Autoimmune progesterone dermatitis (APD) is a condition in which the menstrual cycle is associated with a number of skin findings such as urticaria, eczema, angioedema, and others. In affected women, it occurs 3–10 days prior to the onset of menstrual flow, and resolves 2 days into menses. Women with irregular menses may not have this clear correlation, and therefore may be missed. We present a case of APD in a woman with irregular menses and urticaria/angioedema for over 20 years, who had not been diagnosed or correctly treated due to the variable timing of skin manifestations and menses. In addition, we review the medical literature in regards to clinical features, pathogenesis, diagnosis, and treatment options.
dc.titleAutoimmune progesterone dermatitis in a patient with endometriosis: case report and review of the literature
dc.typeArticleen_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/112472/1/12948_2004_Article_11.pdf
dc.identifier.doi10.1186/1476-7961-2-10en_US
dc.language.rfc3066en
dc.rights.holderBaptist and Baldwin.
dc.date.updated2015-08-07T17:30:40Z
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.